Related Experiment Video
Updated: Oct 13, 2026

A New Murine Model of Endovascular Aortic Aneurysm Repair
Published on: July 7, 2013
Treatment of Acute Ischemic Stroke due to Large Vessel Occlusion With COVID-19: Experience From Paris
Simon Escalard1, Benjamin Maïer1, Hocine Redjem1
1From the Interventional Neuroradiology Department, Rothschild Foundation Hospital, Paris, France.
Insights
COVID-19 patients with acute ischemic stroke due to large vessel occlusion (LVO) experienced poor outcomes despite timely treatment. Further research into alternative pharmacological approaches is needed for these high-risk stroke patients.
Area of Science:
- Neurology
- Infectious Diseases
- Cardiovascular Research
Background:
- Coronaviruses disease 2019 (COVID-19) is associated with increased stroke incidence.
- Limited data exist on outcomes for COVID-19 patients experiencing acute ischemic stroke due to large vessel occlusion (LVO).
Purpose of the Study:
- To report initial experiences and outcomes of treating acute ischemic stroke with LVO in COVID-19 patients.
Main Methods:
- Retrospective analysis of 10 consecutive COVID-19 patients with acute ischemic stroke due to LVO.
- Evaluation of clinical and radiological findings, treatments (intravenous alteplase, mechanical thrombectomy), and short-term outcomes.
Main Results:
- Six out of ten patients (60%) died in the hospital.
- Successful recanalization was achieved in 90% of patients, but 40% experienced early cerebral reocclusion.
- No patients showed early neurological improvement despite prompt interventions.
Conclusions:
- Standard best medical care, including mechanical thrombectomy, yielded poor outcomes in COVID-19 patients with LVO stroke.
- Investigating alternative pharmacological strategies is crucial to address COVID-19-associated inflammatory and coagulation disorders in stroke management.
Background And Purpose:
Higher rates of strokes have been observed in patients with coronavirus disease 2019 (COVID-19), but data regarding the outcomes of COVID-19 patients suffering from acute ischemic stroke due to large vessel occlusion (LVO) are lacking. We report our initial experience in the treatment of acute ischemic stroke with LVO in patients with COVID-19.
Methods:
All consecutive patients with COVID-19 with acute ischemic stroke due to LVO treated in our institution during the 6 first weeks of the COVID-19 outbreak were included. Baseline clinical and radiological findings, treatment, and short-term outcomes are reported.
Results:
We identified 10 patients with confirmed COVID-19 treated for an acute ischemic stroke due to LVO. Eight were men, with a median age of 59.5 years. Seven had none or mild symptoms of COVID-19 at stroke onset. Median time from COVID-19 symptoms to stroke onset was 6 days. All patients had brain imaging within 3 hours from symptoms onset. Five patients had multi-territory LVO. Five received intravenous alteplase. All patients had mechanical thrombectomy. Nine patients achieved successful recanalization (mTICI2B-3), none experienced early neurological improvement, 4 had early cerebral reocclusion, and a total of 6 patients (60%) died in the hospital.
Conclusions:
Best medical care including early intravenous thrombolysis, and successful and prompt recanalization achieved with mechanical thrombectomy, resulted in poor outcomes in patients with COVID-19. Although our results require further confirmation, a different pharmacological approach (antiplatelet or other) should be investigated to take in account inflammatory and coagulation disorders associated with COVID-19.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Transient Ischemic Attack l: Introduction

